Advanced Computer Software Group plc Goes Private in £750 Million Deal with Vista

Leading UK software provider, Advanced Computer Software Group ("Advanced"), has been acquired by Vista Equity Partners ("Vista"), a private equity firm with over $14 billion in committed capital, for an enterprise value of £750 million. Shareholders will receive 140 pence per share equating to an equity value of approximately £725 million. The takeover puts Advanced in a powerful financial position to invest in and develop the business through the next phase of growth, supporting its ambition to become a major global player.

"This acquisition means we now have the major financial backing we need to support us through our next phase of growth and establish our position as a serious global player," said Vin Murria, CEO of Advanced Computer Software Group. "Our customers will benefit from increased investment in our product and services as we continue to offer innovative and leading edge technology solutions implemented both on-premise and, increasingly, via a subscription model."

Founded in 2008, Advanced provides healthcare, business and learning management software and services. It is the third-largest UK-based software provider to the UK market, with more than 2,000 employees and 20,000 customers. The group has grown revenue to more than £200 million through a programme of complementary acquisitions and strong organic growth.

"Advanced has a strong history of delivering mission-critical and high ROI solutions to its customers," said Brian Sheth, Co-Founder and President of Vista Equity Partners. "Vista will help Advanced build on that success by contributing professional expertise, proven best practices, and management techniques that will help Advanced continue to deliver operational, product and service excellence."

In 2014, Advanced won Tech Company of the Year in PwC's UK Tech Awards and was ranked in the Deloitte UK Technology Fast 50, which recognises the 50 fastest growing technology companies in the UK.

About Vista Equity Partners
Vista Equity Partners, a US-based private equity firm with offices in Austin, Chicago and San Francisco, with over $14 billion in cumulative capital commitments, currently invests in dynamic, successful software, data and technology-based organisations led by world-class management teams with long-term perspective. Vista is a value-added investor, contributing professional expertise and multi-level support towards companies realizing their full potential. Vista’s investment approach is anchored by a sizable long-term capital base, experience in structuring technology oriented transactions, and proven management techniques that yield flexibility and opportunity in private equity investing.

About Advanced Computer Software Group plc
Advanced Computer Software Group plc (Advanced) is a leading supplier of software and IT services to both the public and private sectors which assist organisations to improve efficiency and reduce costs.

The Group operates as three divisions:

  • Advanced Health & Care sells a range of products to the NHS and private healthcare sector including patient workflow management for urgent and unplanned care providers; patient case management for social care providers; mobile applications for care in the community providers and rostering applications for social care settings.
  • Advanced Business Solutions provides accounting, payroll, HR, CRM and document management solutions to local authorities, healthcare organisations, law firms and private sector businesses including banks, manufacturers, retailers, charities and travel companies.
  • Advanced 365 delivers managed services to support Group products and to a wide range of customers including banks and financial institutions, membership bodies and healthcare organisations. Services can be delivered either on-premise or as cloud-based models depending on customers' requirements.

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

Great Start for Ideas and Innovations: D…

8 - 10 April 2025, Berlin, Germany. From 15 October to 15 November 2024, the DMEA invites experts from business, science, politics and practice to actively participate in shaping the congress...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...